Medical Management of Parkinson's Disease: Focus on Neuroprotection

E-ISSN： 1875-6190|9|2|350-359

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.9, Iss.2, 2011-06, pp. : 350-359

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pathological Gambling in Parkinson's Disease: An Update on Medical Management

By Pirritano Domenico Plastino Massimiliano Fava Antonietta Cristiano Dario Gallelli Luca Colica Carmela Bosco Domenico

Current Psychopharmacology, Vol. 1, Iss. 4, 2012-11 ,pp. : 365-374

Bentham Science Publishers

Access to resources Recommend Favorite

Medical Management of Levodopa-Associated Motor Complications in Patients with Parkinson's Disease

By Jankovic Joseph

CNS Drugs, Vol. 21, Iss. 8, 2007-01 ,pp. : 677-692

Adis International

Access to resources Recommend Favorite

Mitochondria: Prospective Targets for Neuroprotection in Parkinson’s Disease

Current Pharmaceutical Design, Vol. 20, Iss. 35, 2014-10 ,pp. : 5558-5573

Bentham Science Publishers

Access to resources Recommend Favorite

New Agents Promote Neuroprotection in Parkinson's Disease Models

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 4, 2012-06 ,pp. : 410-418

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Management of Parkinson's Disease

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 34, Iss. 3, 2004-09 ,pp. : 229-232

John Wiley & Sons Inc

Access to resources Recommend Favorite